CityUHK develops novel “DNA surgery” with therapeutic potential for liver and cardiovascular genetic diseases
Grant and Award Announcement
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 15-Dec-2025 16:11 ET (15-Dec-2025 21:11 GMT/UTC)
WASHINGTON—Too many children and adults living with congenital heart disease (CHD) are being left behind by a system that doesn’t adequately value their care. That’s the message of a new policy statement from the Society for Cardiovascular Angiography & Interventions (SCAI) that highlights broken reimbursement models, undervalued procedures, and barriers to device innovation.
The statement, “Economic Barriers to Interventional Cardiology Care for Adults and Children With Congenital Heart Disease and Potential Policy Solutions,” was published today in JSCAI. It calls for Medicaid payment parity, fairer valuation of CHD procedures, new compensation models, and faster pathways for pediatric device approval.
Adiposity—or the accumulation of excess fat in the body—is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease. But getting the full picture of a person’s risk is harder than it may seem. Traditional measures such as body mass index (BMI) are imperfect, conflating fat and muscle mass and not capturing where in the body fat is located. A new study from researchers at Mass General Brigham and their colleagues found that an AI tool designed to measure body composition could accurately capture details in just three minutes from a body scan. Their results, published in Annals of Internal Medicine, show that not all fat is equally harmful and highlight the potential of using AI to repurpose data from routine scans.
The American College of Cardiology (ACC) released today its second Scientific Statement, Inflammation and Cardiovascular Disease (CVD). The statement emphasizes years of clinical and basic science research, confirming that inflammation is an important underlying contributor to several CVDs, including coronary artery disease and heart failure.
Without early detection, conditions such as congenital heart defects and familial hypercholesterolemia (FH) can quietly disrupt growth, energy levels, and long-term organ function.
Whole Genome Sequencing (WGS) can detect these risks at the earliest possible stage. It shifts cardiac care away from crisis management toward proactive, precision prevention.
Researchers from UC San Diego School of Medicine found that testing for lipoprotein(a) — a genetic risk factor for heart disease — remains uncommon in the United States, despite modest increases over the past decade.
Cardiovascular diseases (CVD) remain the leading cause of disease burden, causing one in three deaths worldwide as a result of population growth, population aging and exposure to a broad range of risks, including increasing rates of obesity and diabetes, according to the latest Global Burden of Disease (GBD) Study special report published today in JACC, the flagship journal of the American College of Cardiology.